|The MMP19 mmp19 (Catalog #MBS9225956) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase.
The MMP19 mmp19 product has the following accession number(s) (GI #4505213) (NCBI Accession #NP_002420) (Uniprot Accession #Q99542). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Endopeptidase that degrades various components of the extracellular matrix, such as aggrecan and cartilage oligomeric matrix protein (comp), during development, haemostasis and pathological conditions (arthritic disease). May also play a role in neovascularization or angiogenesis. Hydrolyzes collagen type IV, laminin, nidogen, nascin-C isoform, fibronectin, and type I gelatin.
Cellular Location: Secreted, extracellular space, extracellular matrix. Tissue Location: Expressed in mammary gland, placenta, lung, pancreas, ovary, small intestine, spleen, thymus, prostate, testis colon, heart and blood vessel walls. Not detected in brain and peripheral blood leukocytes. Also expressed in the synovial fluid of normal and rheumatoid patients. Blood, Bone, Brain, Embryonic Tissue, Eye, Heart, Lung, Ovary, Skin, Uterus tissues are correlated with this protein. Breast Neoplasms, Cardiovascular Diseases, Fibrosis, Hypertrophy, Inflammation, Kidney Diseases, Lung Diseases, Lung Neoplasms, Necrosis, Nervous System Diseases are some of the diseases may be linked to MMP19 Antibody (C-term) Blocking Peptide. The following patways have been known to be associated with this gene.